![C45H56N7O9P Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N,N-bis (1-Methylethyl)phosphoramidit] (ACI)](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C45H56N7O9P Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N,N-bis (1-methylethyl) phosphoramidite] (ACI) Ausgezeechent Bild](https://www.csnvchem.com/uploads/C45H56N7O9P.png)
C45H56N7O9P Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N,N-bis (1-Methylethyl)phosphoramidit] (ACI)
CAS Registréierungsnummer
150780-67-9
H303
| Schlëssel kierperlech Eegeschaften | Wäert | Zoustand |
| Molekulare Gewiicht | 869,94 | - |
| pKa (virausgesot) | 9,16 ± 0,20 | Déi meescht sauer Temperatur: 25 °C |
N#CCCOP(OC1C(OC(N2C= NC=3C(=O)N=C(NC(=O)C(C)C)NC32)C1OC)COC(C=4C=CC=CC4)(C5=CC =C(OC)C=C5)C6=CC=C(OC)C=C6)N(C(C)C)C(C)C
Isomeric SMILES
C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OC)[C@@ H](O1)N2C3=C(N=C2)C(=O)N=C(NC(C(C)C)=O)N3)(C4=CC=C(OC) C=C4)(C5) =CC=C(OC)C=C5)C6=CC=CC=C6
InChI
InChI= 1S/C45H56N7O9P/c1-28(2)41(53)49-44-48-40-37(42(54)50-44)47-27-51(40)43-39(57-9) 38(61-62(59-25-13-24-
46) 52(29(3)4)30(5)6)36(60-43)26-58-45(31-14-11-10-12-15-31,32-16-20-34( 55-7)21-17-32)33-18-22-35(56-8)23-19-33/h10-12,14-23,27 -30,36,38-39,43H,13, 25-26H2,1-9H3,(H2,48,49,50,53,54)/t36-,38-,39-,43-,62?/m1/s1
InChI Schlëssel
IRRDHRZUOZNWDJ-MLLDKZSOSA-N
1 Aneren Numm fir dës Substanz
Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl bis(1-methylethyl) phosphoramidit] (9CI)
Spektrum verfügbar
13 C NMR
Hetero NMR
Eegeschafte verfügbar
Biologesch
Chemesch
Lipinski
Struktur Zesummenhang
| Immobilie | Wäert | Zoustand | Quell |
| Biokonzentratiounsfaktor | 183 | pH 1; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 3890 | pH 2; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 35500 | pH 3; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,08 x 105 | pH 4; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,36 x 105 | pH 5; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,39 x 105 | pH 6; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,38 x 105 | pH 7; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 1,24 x 105 | pH 8; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 63 600 | pH 9; Temperatur: 25 °C | (1) ACD |
| Biokonzentratiounsfaktor | 11 900 | pH 10; Temperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 220 | pH 1; Temperatur: 25 °C | (1) ACD |
| Koc | 4680 | pH 2; Temperatur: 25 °C | (1) ACD |
| Koc | 42600 | pH 3; Temperatur: 25 °C | (1) ACD |
| Koc | 1,30 x 105 | pH 4; Temperatur: 25 °C | (1) ACD |
| Koc | 1,63 x 105 | pH 5; Temperatur: 25 °C | (1) ACD |
| Koc | 1,67 x 105 | pH 6; Temperatur: 25 °C | (1) ACD |
| Koc | 1,65 x 105 | pH 7; Temperatur: 25 °C | (1) ACD |
| Koc | 1,49 x 105 | pH 8; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Koc | 7 6400 | pH 9; Temperatur: 25 °C | (1) ACD |
| Koc | 14 200 | pH 10; Temperatur: 25 °C | (1) ACD |
| log D | 4.19 | pH 1; Temperatur: 25 °C | (1) ACD |
| log D | 5,52 | pH 2; Temperatur: 25 °C | (1) ACD |
| log D | 6,48 | pH 3; Temperatur: 25 °C | (1) ACD |
| log D | 6,96 | pH 4; Temperatur: 25 °C | (1) ACD |
| log D | 7.06 | pH 5; Temperatur: 25 °C | (1) ACD |
| log D | 7.07 | pH 6; Temperatur: 25 °C | (1) ACD |
| log D | 7.07 | pH 7; Temperatur: 25 °C | (1) ACD |
| log D | 7.02 | pH 8; Temperatur: 25 °C | (1) ACD |
| log D | 6,73 | pH 9; Temperatur: 25 °C | (1) ACD |
| log D | 6.00 | pH 10; Temperatur: 25 °C | (1) ACD |
| logP | 7,072±0,721 | Temperatur: 25 °C | (1) ACD |
| Mass Intrinsesch Solubilitéit | 1,2 x 10-4 g/l | Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 0,096 g/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 4,3 x 10-3 g/L | pH 2; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 4,8 x 10-4 g/L | pH 3; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,6 x 10-4 g/L | pH 4; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,2 x 10-4 g/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,2 x 10-4 g/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,2 x 10-4 g/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,4 x 10-4 g/l | pH 8; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 2,7 x 10-4 g/L | pH 9; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,4 x 10-3 g/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Mass Solubilitéit | 1,2 x 10-4 g/l | Ongebuffert Waasser pH 7,00; Temperatur: 25 °C | (1) ACD |
| Molar Intrinsesch Solubilitéit | 1,4 x 10-7 mol/l | Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,1 x 10-4 mol/l | pH 1; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,0 x 10-6 mol/l | pH 2; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 5,5 x 10-7 mol/l | pH 3; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,8 x 10-7 mol/l | pH 4; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,4 x 10-7 mol/l | pH 5; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,4 x 10-7 mol/l | pH 6; Temperatur: 25 °C | (1) ACD |
| Immobilie | Wäert | Zoustand | Quell |
| Molar Solubilitéit | 1,4 x 10-7 mol/l | pH 7; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,6 x 10-7 mol/l | pH 8; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 3,1 x 10-7 mol/l | pH 9; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,6 x 10-6 mol/l | pH 10; Temperatur: 25 °C | (1) ACD |
| Molar Solubilitéit | 1,4 x 10-7 mol/l | Ongebuffert Waasser pH 7,00; Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 869,94 | ||
| pKa | 9,16 ± 0,20 | Déi meescht sauer Temperatur: 25 °C | (1) ACD |
| pKa | 3,45±0,70 | Déi meescht Basistemperatur: 25 °C | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Zoustand | Quell |
| Fräi rotéierbar Obligatiounen | 19 | (1) ACD | |
| H Akzepter | 16 | (1) ACD | |
| H Donateuren | 2 | (1) ACD | |
| H Donateur / Akzeptanz Zomm | 18 | (1) ACD | |
| logP | 7,072±0,721 | Temperatur: 25 °C | (1) ACD |
| Molekulare Gewiicht | 869,94 |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
| Immobilie | Wäert | Conditioun Quell |
| Polar Fläch Beräich | 194 A2 | (1) ACD |
(1) Berechent mat Advanced Chemistry Development (ACD/Labs) Software V11.02 (© 1994-2023 ACD/Labs)
Spektrum verfügbar
1H NMR
13 C NMR
| Code | Gefor Ausso | Quell |
| H303 | Kann schiedlech sinn wann se schlucken | Expert Curated |
![C42H52N5O9P Cytidin, N-acetyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] ( ACI)](https://www.csnvchem.com/uploads/C42H52N5O9P-Cytidine-300x300.png)
![C43H55N4O10P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)- 5-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-) Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C43H55N4O10P-Uridine-300x300.png)
![C47H60N7O10P Guanosin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3'- [2-cyanoethyl N ,N-bis(1-Methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C47H60N7O10P-Guanosine-300x300.png)
![C40H49N4O9P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C40H49N4O9P-Uridine-300x300.png)
![C39H46FN4O8P Uridin, 5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI) )](https://www.csnvchem.com/uploads/C39H46FN4O8P-Uridine-300x300.png)
![C48H54N7O8P Adenosin, N-benzoyl-5'-O- [bis(4-methoxyphenyl)phenylmethyl]-2'- O-methyl-, 3'- [2-cyanoethyl-N,N-bis(1-methylethyl)phosphoramidit] (ACI)](https://www.csnvchem.com/uploads/C48H54N7O8P-300x300.png)